Symbol="AVRO"
AssetType="Common Stock"
Name="AVROBIO Inc"
Description="AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts."
CIK="1681087"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="ONE KENDALL SQUARE, BLDG. 300, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="67687000"
EBITDA="-87887000"
PERatio="None"
PEGRatio="None"
BookValue="2.754"
DividendPerShare="0"
DividendYield="0"
EPS="-0.14"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.398"
ReturnOnEquityTTM="-0.0456"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.14"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="3.25"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.355"
EVToRevenue="-"
EVToEBITDA="0.619"
Beta="1.576"
num_52WeekHigh="1.93"
num_52WeekLow="0.56"
num_50DayMovingAverage="1.316"
num_200DayMovingAverage="1.071"
SharesOutstanding="44530700"
DividendDate="None"
ExDividendDate="None"
symbol="AVRO"
open="1.50"
high="1.53"
low="1.49"
price="1.51"
volume="181511.00"
latest_trading_day="2023-08-25"
previous_close="1.52"
change="-0.01"
change_percent="-0.6579%"
aroon_positive_momentum_days="84"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="2022051"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.53"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_negative_thumbnail_id_2="171"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0005.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="629"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0079.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
